title: The relationship of ischemia-reperfusion injury of transplanted lung and the up-regulation of major histocompatibility complex II on host peripheral lymphocytes.
abstract: OBJECTIVE
  This study was designed to examine the relationship between ex vivo preservation time of the transplanted lung and the extent of injury and to relate this to the severity of rejection with and without allogenicity.
  
  
  METHODS
  Single lung transplantation was performed on two groups of domestic swine. Group A (n = 7) and group B (n = 6) had ex vivo preservation times of 4 and 15 hours, respectively, at 4 degrees C hypothermia. Group C (n = 6) underwent 2 hours of warm ischemia via dissection and isolation of the left lung with ligation of its bronchial artery and crossclamping of the left pulmonary artery, vein, and bronchus without explantation. Assessment measures included lung function, antioxidant enzyme activities in the plasma and lung tissue, levels of inflammatory mediators in the recipient plasma, and quantification of major histocompatibility complex II HLA-DR-beta on host peripheral lymphocytes.
  
  
  RESULTS
  All groups demonstrated increases in interleukin-10, lung weight, and HLA-DR-1beta expression and decreases in lung-tissue antioxidant enzyme activities, gas exchange, and lung compliance. There was a strong positive correlation between ex vivo preservation time and the expression of HLA-DR-beta and a negative correlation between ischemic time and lung-tissue superoxide dismutase.
  
  
  CONCLUSIONS
  These results suggest that the intensity of the host immunogenic response is related to the severity of ischemia-reperfusion injury and is independent of tissue incompatibility and/or the type of ischemic insult. We conclude that the extension of ex vivo preservation time may predispose the transplanted lung to more severe rejection.
authors.affiliation: Department of Surgery, University of Brisith Columbia, Vancouver Hospital and Health Sciences Centre, The British Columbia Transplant Society, Canada.
authors.forename: A K
authors.initials: AK
authors.lastname: Qayumi
authors.forename: M N
authors.initials: MN
authors.lastname: Nikbakht-Sangari
authors.forename: D V
authors.initials: DV
authors.lastname: Godin
authors.forename: J C
authors.initials: JC
authors.lastname: English
authors.forename: K J
authors.initials: KJ
authors.lastname: Horley
authors.forename: P A
authors.initials: PA
authors.lastname: Keown
authors.forename: S P
authors.initials: SP
authors.lastname: Lim
authors.forename: D M
authors.initials: DM
authors.lastname: Ansley
authors.forename: M S
authors.initials: MS
authors.lastname: Koehle
mesh_terms: D000818:Animals; D017252:CD3 Complex / Q000378:metabolism; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006684:HLA-DR Antigens / Q000378:metabolism*; D016867:Immunocompromised Host; D007150:Immunohistochemistry; D016753:Interleukin-10 / Q000378:metabolism; D016040:Lung Transplantation; D008213:Lymphocyte Activation / Q000276:immunology; D009926:Organ Preservation; D015427:Reperfusion Injury / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D012129:Respiratory Function Tests; D013482:Superoxide Dismutase / Q000378:metabolism; D013552:Swine; D013601:T-Lymphocytes / Q000378:metabolism* / Q000473:pathology; D015854:Up-Regulation
chemical_list: D017252:CD3 Complex; D006684:HLA-DR Antigens; D016753:Interleukin-10; D013482:Superoxide Dismutase